home
german
disclaimer
sitemap
suche
ok
print
links
imprint
Company
Company Profile
Business Strategy
Management
Contact
Imprint
Products & Pipeline
Products and clinical projects
Targeted Indication
News
News
Press Releases
Ad hoc Press Releases
Conferences and Events
Webcast
Investor Relations
Investor Relations Contact
The MediGene Stock
Financial Calendar
Conference Calendar
Reports
General Meeting
News
Analysts Coverage
Corporate Governance
Company Presentation
Career Opportunities
Career Opportunities
Partnering & Licensing
Partnering & Licensing
Sitemap
Medigene AG -Search
Company
Company Profile
Business Strategy
Management
Contact
Imprint
Products & Pipeline
Products and clinical projects
Drugs on the market:
Eligard
®
Projects in clinical development:
EndoTAG
®
-1
RhuDex
®
Oncolytic viruses (HSV)
Technologies:
EndoTAG ®
AAVLP
Oncolytic viruses (HSV)
Strategic Investments
Immunocore Ltd.
Catherex, Inc.
Targeted Indication
News
News
Press Releases
Medigene AG -
Ad hoc Press Releases
Conferences and Events
Webcast
Medigene AG - Press Releases
Investor Relations
Investor Relations Contact
The MediGene Stock
Share Prices
Quotes & Charts
Capital Measures
Capital measures
Shara Data
Medigene AG -
Financial Calendar
Conference Calendar
Reports
General Meeting
Archive
2009
2010
2011
News
Analysts Coverage
Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG -
Medigene AG - Corporate Governance
Company Presentation
Career Opportunities
Career Opportunities
Our guiding principles
Our guiding principles
Job Vacancies
Jobs - San Diego
Job Vacancies
Partnering & Licensing
Partnering & Licensing